1. Home
  2. BLBX vs NXTC Comparison

BLBX vs NXTC Comparison

Compare BLBX & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackboxstocks Inc.

BLBX

Blackboxstocks Inc.

HOLD

Current Price

$12.20

Market Cap

41.7M

Sector

Technology

ML Signal

HOLD

Logo NextCure Inc.

NXTC

NextCure Inc.

HOLD

Current Price

$12.84

Market Cap

49.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLBX
NXTC
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7M
49.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BLBX
NXTC
Price
$12.20
$12.84
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$23.00
AVG Volume (30 Days)
91.4K
31.5K
Earning Date
10-16-2025
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,387,828.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.48
$2.69
52 Week High
$17.75
$15.74

Technical Indicators

Market Signals
Indicator
BLBX
NXTC
Relative Strength Index (RSI) 66.02 42.28
Support Level $9.70 $11.57
Resistance Level $12.80 $13.60
Average True Range (ATR) 1.03 1.11
MACD 0.20 -0.21
Stochastic Oscillator 73.89 28.10

Price Performance

Historical Comparison
BLBX
NXTC

About BLBX Blackboxstocks Inc.

Blackboxstocks Inc is a financial technology and social media hybrid platform offering real-time proprietary analytics and news for stock and options traders of all levels. Its web-based software (the Blackbox System) employs predictive technology enhanced by artificial intelligence to find volatility and unusual market activity that may result in a rapid change in the price of a stock or option. It provides users with a fully interactive social media platform that is integrated into its dashboard, enabling users to exchange information and ideas quickly and efficiently through a common network. The company introduced a live audio/video feature that allows members to broadcast on their channels to share trading strategies and market insight within the Blackbox community.

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Share on Social Networks: